Marligen Biosciences

Ijamsville, United States Founded: 2001 • Age: 25 yrs Acquired By OriGene
Limited information available

About Marligen Biosciences

Marligen Biosciences is a company based in Ijamsville (United States) founded in 2001 was acquired by OriGene in October 2009.. Marligen Biosciences has raised $2.38 million across 2 funding rounds from investors including OriGene and Emerging Technology Partners.

  • Headquarter Ijamsville, United States
  • Phone
    *********
  • Website
    *********
Operational Areas
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $2.38 M (USD)

    in 2 rounds

  • Latest Funding Round
    $2.3 M (USD), Series A

    May 10, 2004

  • Investors
    OriGene

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    OriGene

    (Oct 16, 2009)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Marligen Biosciences

Marligen Biosciences has successfully raised a total of $2.38M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $2.3 million completed in May 2004. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Series A — $2.3M
  • First Round

    (01 Aug 2003)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2004 Amount Series A - Marligen Biosciences Valuation Emerging Technology Partners
Aug, 2003 Amount Seed - Marligen Biosciences Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Marligen Biosciences

Marligen Biosciences has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include OriGene and Emerging Technology Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Proteins, antibodies, and molecular tools are manufactured for research applications.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Marligen Biosciences

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Marligen Biosciences

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Marligen Biosciences Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Marligen Biosciences

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Marligen Biosciences

Frequently Asked Questions about Marligen Biosciences

When was Marligen Biosciences founded?

Marligen Biosciences was founded in 2001 and raised its 1st funding round 2 years after it was founded.

Where is Marligen Biosciences located?

Marligen Biosciences is headquartered in Ijamsville, United States. It is registered at Ijamsville, Maryland, United States.

Is Marligen Biosciences a funded company?

Marligen Biosciences is a funded company, having raised a total of $2.38M across 2 funding rounds to date. The company's 1st funding round was a Seed of $75K, raised on Aug 01, 2003.

What does Marligen Biosciences do?

Limited information available.

Who are Marligen Biosciences's investors?

Marligen Biosciences has 2 investors. Key investors include OriGene, and Emerging Technology Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available